APPENDIX III
SOME KEY
RESEARCH PAPERS
THAT SUGGEST
A POSSIBLE
LINK BETWEEN
VACCINATION AND
DEGENERATION INTO
AUTISM OR
OTHER SERIOUS
CONDITIONS, OR
SUPPORT THE
POSSIBILITY OF
DAMAGE
410. The following list is not exhaustive:
— Fudenburg, H H, Dialysable lymphocyte
extract in infantile onset autism; a pilot study, Biotherapy,
1996, 9, 143-7.
— Iannetti P et al, Immunisations
and brain damage, Pediatr Oggi Med Chir 14/3-4 (31-136), 1994.
— Schwartz, R, Advances in clinical
immunology, Practitioner, October 1967, p 514 onwards.
— Sabra, Bellanti, Colon, International
Centre for Interdisciplinary Studies of Immunology, Georgetown
University Medical Centre, letter, Lancet, July 1998.
— Takashi Fujinaga et al, a prefecture-wide
survey of mumps meningitis associated with MMR vaccine, Paediatric
Infectious Disease Journal (R), March 1991.
— Halsey et al, Increased mortality
after high titer measles vaccine, Paediatric Infectious Disease
Journal (R), June 1993.
— Odent, M. Long term effects of
early vaccinations, Primal Health Research Vol 2, no 1, p
6, Summer 1994.
— Singh et al, Antibodies to myelin
basic protein in children with autistic behaviour, Singh et
al, Brain, Behaviour and Immunity, vol 7, pp 97-103 (1993).
— Farrington et al, A new method
for active surveillance of adverse events, Lancet, Vol 345,
pp 567-9.
— Thompson P et al, Is measles vaccination
a risk factor for inflammatory bowel disease?, Lancet, Vol
345, pp 1071-4, April 1995.
— Warren R et al, Decreased plasma
concentrations of the C4B complement protein in autism, Archives
of Pediatrics and Adolescent Medicine, vol 148, 180-3, February
1994.
— Montinari et al, Role of Immunogenetics
in the Diagnosis of Past-vaccinal CNS Pathology, Department
of Pediatric Surgery, University of Bari, paper presented May
1996.
— Etiology of infantile autism:
a review of recent advances in genetic and neurobiological research,
Journal of Psychiatry and Neuroscience, Vol 24, no 2, March 1999,
pp 103-15.
— Anemia of a mild viral infection
(using) the measles vaccine as a model, Pediatrics, Vol 84,
no 5, November 1989, pp 851-5.
— Acute encepalopathy followed by
permanent brain injury or death associated with further attenuated
measles vaccines: a review of claims submitted to the National
Vaccine Injury Compensation Program, Pediatrics, Vol 101,
no 3, Part 1, March 1998, pp 383-7.
— Laitinen et al, Very high measles
and rubella virus antibody titers associated with hepatitis, systemic
lupus erythematosus and infectious mononucleosis, Lancet,
vol 1, February 1974, pp 194-7.
— Serum autoantibodies to brain
in Landau-Kleffner variant, autism and other neurologic disorders,
Journal of Pediatrics, vol 134. No 5, May 1999, pp 607-613.
— Bacterial translocation from the
gastrointestinal tract, Trends in Microbiology, Vol 3, no
4, pp. 149-54, April 1995.
— Paramyxovirus infections in childhood
and subsequent inflammatory bowel disease, Gastroenterology,
Vol 116, no 4, pp 796-803, April 1999.
— D'Eufemia et al, Abnormal intestinal
permeability in children with autism, Acta Pediatrica 85,
1076-9, 1996.
— Singh, V, Plasma increase of interleukin-12
and interferon-gamma: pathological significance in autism,
Journal of Neuroimmunology, 2915 1996).
— Gupta, S, Immunology and immunological
treatment of autism, conference paper, University of California.
— Gupta et al, Dysregulated immune
system in children with autism, beneficial effects of intravenous
immune globulin on autistic characteristics, Journal of Autism
and Development Disorders, Vol 26, no 4, 1996.
— O'Behan, P, Acute disseminated
encephalomyelitis, factsheet, Glasgow University.
— Murch, S et al, autism, inflammatory
bowel disease and MMR vaccine, letter, Lancet, 1998, 351,
908.
— Wakefield, A J et al, Ileal lymphoid
nodular hyperplasia, non-specific colitis and pervasive developmental
disorder in children, Lancet, 1998, 351, 637-41.
— Wakefield, A J, autism, inflammatory
bowel disease and MMR vaccine, letter, Lancet, 1998, 351,
908.
— Bolte, E, Autism and clostridium
tetani, Medical Hypotheses, vol 51, 1998, pp 133-44.
— Wakefield, A J, Autism, inflammatory
bowel disease and MMR vaccine, letter, Lancet, 1998, 351,
1356.
— Zecca et al, Elevated rubeola
titers in autistic children linked to MMR vaccine, abstract
submitted to the National Institutes of Health, 1997-8.
— Walker-Smith, J A, Autism, inflammatory
bowel disease and MMR vaccine, letter, Lancet, 1998, 351,
1356-7.
— Singh et al, Serological association
of measles virus, Clinical Immunology and Immunopathology,
1998, 89(1), 105-8.
|
